Clinical trial

Aspirin for Treatment of Multiple Sclerosis-Related Fatigue

NCT00467584

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE3

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2014-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Fatigueunresolved

Interventions

High Dose Aspirin (1300 mg/day)DRUG

Low Dose Aspirin (162 mg/day)DRUG

PlaceboDRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Multiple Sclerosis Societycollaborator

Mapped research locations

ScottsdaleArizona, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00467584 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.